Keyphrases
Anticoagulation
100%
Heparin
100%
Unfractionated Heparin
100%
Glycoprotein IIb/IIIa Inhibitors
100%
Tirofiban
100%
Cardiopulmonary Bypass
100%
Heparin-induced Thrombocytopenia
100%
Platelet Glycoproteins
100%
Renal Impairment
100%
Hirudin
60%
Activated Partial Thromboplastin Time (aPTT)
40%
Bolus
40%
Venous Thromboembolism
40%
D-dimer
40%
Embolism
20%
After Surgery
20%
Clinical Evidence
20%
Enzyme-linked Immunosorbent Assay (ELISA)
20%
Thrombosis
20%
Heparin Anticoagulation
20%
Heparin-induced
20%
Prostacyclin
20%
Systemic Hypotension
20%
Platelets
20%
Coagulation
20%
Antithrombotic Therapy
20%
Short-acting
20%
Adenosine Diphosphate
20%
Transfusion
20%
Platelet Inhibition
20%
Thromboembolic Complications
20%
Danaparoid
20%
Postoperative Period
20%
Abciximab
20%
Standard Heparin
20%
Platelet Aggregometry
20%
Postoperative Bleeding
20%
Activated Clotting Time
20%
Platelet Function Assay
20%
Intraoperative Blood Loss
20%
Anticoagulation Strategy
20%
Platelet Aggregation Inhibitors
20%
Platelet Factor 4
20%
Re-exploration
20%
Perioperative Anticoagulation
20%
Medicine and Dentistry
Anticoagulation
100%
Heparin
100%
Tirofiban
100%
Cardiopulmonary Bypass
100%
Heparin-Induced Thrombocytopenia
100%
Platelet Glycoprotein IIb/IIIa
100%
Fibrinogen Receptor Antagonist
100%
Platelet
33%
Hirudin
33%
Venous Thromboembolism
22%
Partial Thromboplastin Time
22%
Postoperative Hemorrhage
22%
D-Dimer
22%
Thrombosis
11%
Infusion
11%
Thromboembolism
11%
Prostacyclin
11%
Hypotension
11%
Antithrombotic Therapy
11%
Adenosine Diphosphate
11%
Enzyme Linked Immunosorbent Assay
11%
Danaparoid
11%
Postoperative Period
11%
Abciximab
11%
Platelet Aggregation Assay
11%
Thrombocyte Factor 4
11%
Activated Clotting Time
11%
Antiplatelet Drug
11%
Nursing and Health Professions
Heparin
100%
Anticoagulation
100%
Tirofiban
100%
Heparin Induced Thrombocytopenia
100%
Cardiopulmonary Bypass
100%
Fibrinogen Receptor Antagonist
100%
Hirudin
33%
Venous Thromboembolism
22%
Postoperative Hemorrhage
22%
D Dimer
22%
Activated Partial Thromboplastin Time
22%
Infusion
11%
Thrombosis
11%
Anticoagulant Agent
11%
Adenosine Diphosphate
11%
Postoperative Period
11%
Thromboembolism
11%
Platelet Aggregation Assay
11%
Danaparoid
11%
Enzyme Linked Immunosorbent Assay
11%
Blood Clotting Time
11%
Thrombocyte Factor 4
11%
Prostacyclin
11%
Hypotension
11%
Antithrombocytic Agent
11%
ReoPro
11%
Biochemistry, Genetics and Molecular Biology
Heparin
100%
Platelet Glycoprotein IIb/IIIa
100%
Tirofiban
100%
Anticoagulation
100%
Heparin-Induced Thrombocytopenia
100%
Hirudin
33%
Platelet
33%
Partial Thromboplastin Time
22%
D-Dimer
22%
Thrombocyte Aggregation
22%
Enzyme
11%
Adenosine Diphosphate
11%
Activated Clotting Time
11%
Abciximab
11%
Platelet Factor 4
11%
Prostacyclin
11%
Pharmacology, Toxicology and Pharmaceutical Science
Heparin
100%
Heparin Induced Thrombocytopenia
100%
Fibrinogen Receptor Antagonist
100%
Tirofiban
100%
Hirudin
33%
Thromboplastin
22%
Venous Thromboembolism
22%
D Dimer
22%
Postoperative Hemorrhage
22%
Thrombosis
11%
Enzyme-Linked Immunosorbent Assay
11%
Adenosine Diphosphate
11%
Hypotension
11%
Thromboembolism
11%
Antithrombotic Therapy
11%
Danaparoid
11%
Antithrombocytic Agent
11%
Clotting Time
11%
Abciximab
11%
Thrombocyte Factor 4
11%
Prostacyclin
11%